Teva Pharmaceutical to pay $519 million to resolve FCPA allegations
A Russian subsidiary of the Israel-based drug manufacturer agreed to plead guilty to participating in a $65 million bribe scheme in Russia, while the parent company will enter into a three-year deferred prosecution agreement.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10